Pulmonary Fibrosis News

December 4, 2020December 4, 2020

Phase 3 INOpulse Trial Enrolls First Patient at Risk of PF-associated PH

A Phase 3 clinical trial evaluating Bellerophon Therapeutics’ investigational therapy INOpulse — inhaled nitric oxide — in patients with pulmonary fibrosis (PF) at risk of developing pulmonary hypertension (PH) has enrolled its first ... Read more

December 2, 2020December 2, 2020

Queen Latifah, Bernie Williams Join in ILD Film ‘Beyond Breathless’

Pulmonary Fibrosis News

The new documentary “Beyond Breathless,” spotlighting interstitial lung disease (ILD) patients and their families, will feature actress and producer Queen Latifah and former NY Yankee Bernie Williams. “Beyond Breathless” premieres ... Read more

December 1, 2020December 1, 2020

PF Clinical Researcher Receives NIH Award for Career Development

Pulmonary Fibrosis News

The National Institutes of Health (NIH) has awarded a researcher at the University of Pennsylvania the K08 Award for his research in pulmonary fibrosis (PF), the Pulmonary Fibrosis Foundation (PFF) announced. PFF ... Read more

November 30, 2020November 30, 2020

New Mouse Study Will Investigate EmtinB as Post-COVID Fibrosis Treatment

COVID-19 News, Pulmonary Fibrosis News

NeuroScientific Biopharmaceuticals, the Institute for Respiratory Health, and the University of Western Australia (UWA) have initiated a preclinical study assessing the potential of EmtinB and other related, lab-made compounds to ... Read more

November 25, 2020November 25, 2020

Potential IPF Treatment, LYT-100, Shows Good Tolerability in Trial

COVID-19 News, Pulmonary Fibrosis News

Oral LYT-100 (deupirfenidone) was found to be safe and well-tolerated at all doses in an ongoing Phase 1 trial evaluating its potential to treat disorders involving inflammation and fibrosis, such ... Read more

November 24, 2020November 24, 2020

‘Second Wind’ Short Film Brings PF, Organ Donation Into Sharp Focus

Pulmonary Fibrosis News

The Three Lakes Foundation, a nonprofit supporting better ways of diagnosing and treating pulmonary fibrosis (PF), announced the release of “Second Wind,” a short documentary film highlighting the need for organ ... Read more

November 23, 2020November 23, 2020

1st Patient Enrolled in Trial Testing Ofev on Post-COVID-19 PF

COVID-19 News, Pulmonary Fibrosis News

The first patient has enrolled in a clinical trial to understand the effect of Ofev (nindetanib) on adults who developed pulmonary fibrosis (PF) following acute lung injury from COVID-19 infection. ... Read more

November 20, 2020November 20, 2020

PF Foundation Invites Young Scientists to Apply for 2021 PFF Scholars Program

Pulmonary Fibrosis News

The Pulmonary Fibrosis Foundation (PFF), which supports research that advance understanding and better ways of treating pulmonary fibrosis (PF), is calling for submissions for next year’s PFF Scholars program for emerging scientists. ... Read more

November 18, 2020November 18, 2020

Phase 2 Trial of C21, Potential Oral Therapy for IPF, Opens

COVID-19 News, Pulmonary Fibrosis News

A first patient has been enrolled in a proof-of-concept Phase 2 trial of C21 (VP01), Vicore Pharma’s investigational oral therapy for idiopathic pulmonary fibrosis (IPF) and other lung diseases. “We ... Read more

November 17, 2020November 17, 2020

PFF Awareness Campaign, ‘Pinpoint PF,’ Opening in December

Pulmonary Fibrosis News

The Pulmonary Fibrosis Foundation (PFF) plans to launch “Pinpoint PF,” an educational and awareness campaign for those at risk of pulmonary fibrosis (PF) or showing symptoms, in December. “We introduced ... Read more

November 16, 2020November 16, 2020

New Targeted Therapies May Ease Pulmonary Fibrosis, Studies Find

Pulmonary Fibrosis News

Newly developed therapies may hold promise for the treatment of pulmonary fibrosis, as described in two studies. The therapies, which are expected to move into clinical trials in the next ... Read more

November 13, 2020November 13, 2020

Grant Will Help Researchers Engineer Lung Tissue to Find PF Treatments

COVID-19 News, Pulmonary Fibrosis News

The National Heart, Lung and Blood Institute, part of the National Institutes of Health, has granted $920,000 to a team of researchers at the University at Buffalo (UB) to develop a ... Read more

November 11, 2020November 11, 2020

Esbriet or Ofev Reduce Inflammatory and Oxidative Stress Markers in IPF, Small Study Shows

Pulmonary Fibrosis News

Esbriet (pirfenidone) or Ofev (nintedanib) treatment in adults with idiopathic pulmonary fibrosis (IPF) led to changes in blood markers reflecting reduced systemic inflammation and oxidative stress after 24 weeks of ... Read more

November 10, 2020November 10, 2020

Bridge Biotherapeutics, Boehringer Ingelheim End Agreement to Develop BBT-877

Pulmonary Fibrosis News

Bridge Biotherapeutics and Boehringer Ingelheim ended a collaboration and license agreement to develop BBT-877, a potential treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic disorders. The companies entered into ... Read more

November 9, 2020November 9, 2020

Partnership to Advance in Testing OATD-01, Potential IPF Therapy

Pulmonary Fibrosis News

Galapagos and OncoArendi Therapeutics have entered into an exclusive agreement for the global development and commercialization of OncoArendi’s OATD-01, an investigational treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. ... Read more